INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
77,575,733
Number of holders
283
Total 13F shares, excl. options
66,935,797
Shares change
-1,853,251
Total reported value, excl. options
$2,915,003,332
Value change
-$77,019,585
Put/Call ratio
38%
Number of buys
125
Number of sells
-131
Price
$43.55

Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q4 2023

314 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q4 2023.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 66,935,797 shares of 77,575,733 outstanding shares and own 86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7,012,793 shares), BlackRock Inc. (6,641,845 shares), MORGAN STANLEY (5,270,697 shares), Capital Research Global Investors (4,297,326 shares), WELLINGTON MANAGEMENT GROUP LLP (3,185,293 shares), COOKE & BIELER LP (2,834,604 shares), ALLIANCEBERNSTEIN L.P. (2,725,502 shares), Clearbridge Investments, LLC (2,474,249 shares), Champlain Investment Partners, LLC (2,435,957 shares), and STATE STREET CORP (2,115,767 shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.